Companies: 10,795·Total market cap: $144.5T
Aardvark Therapeutics, Inc. Common Stock

Aardvark Therapeutics, Inc. Common Stock

AARDNASDAQHealthcare● Active
$3.59
$-0.09(-2.45%)
Market Cap$78320822
P/E Ratio
52W High$17.94
52W Low$3.35
Overview

Aardvark Therapeutics, Inc. Common Stock (AARD) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AARD · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.21aard eps ttm · aard earnings per shareEarnings history
PE Ratio (TTM)aard pe ratio ttm · aard price to earningsPE Ratio deep dive
Revenue (TTM)0.00aard revenue ttm · aard annual revenueFull revenue history
Dividend YieldNo Dividenddoes aard pay dividends · aard dividend yieldDividend history
Shares Outstanding21.8Maard shares outstanding · aard floatShares outstanding history
Next EarningsAug 12, 2026Est.aard earnings date · aard next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
aardvark therapeutics, inc. common stock revenue · aard revenue 2025
FY 2025Net Income-$57.6M▼ 179.73% YoY
202320242025
aardvark therapeutics, inc. common stock net income · aard profit 2025
FY 2025EPS$-2.64▼ 177.89% YoY
202320242025
aard eps · aardvark therapeutics, inc. common stock earnings per share 2025
TTM:Revenue: $0.00Net Income: -$69.9MEPS: $-3.21View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy9 analystsis aard a buy · aard analyst rating
Strong Buy
0
Buy
4
Hold
4
Sell
1
Strong Sell
0
12-Month Price Target
$3.00Low
$3.59Current
$22.75Avg Target533.70% upside
$47.00High
aard price target · aard 12 month forecast

Total: 9 · Buy rate: 44.4%

The AARD analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $22.75, representing +533.70% upside from the current price of $3.59.

Stock Performance

Full History
1D-2.17%
1W-8.40%
1M-33.82%
3M-38.46%
YTD-72.58%
1Y-69.18%
5Y-74.84%

About Aardvark Therapeutics, Inc. Common Stock

CEOTien-Li Lee
IPO DateFeb 13, 2025
Employees22
CountryUS

Aardvark Therapeutics, Inc. Common Stock Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's n…

what is aardvark therapeutics, inc. common stock · aard stock overview · aardvark therapeutics, inc. common stock company profile · who is aardvark therapeutics, inc. common stock ceo · aard NASDAQ · aardvark therapeutics, inc. common stock headquarters · aardvark therapeutics, inc. common stock business segments

About Stock Overview & Key Data

Aardvark Therapeutics, Inc. Common Stock (AARD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 13, 2025. As of the latest trading session, AARD stock price is $3.59, with a market capitalization of $78.3M. The stock has returned -69.18% over the past 12 months and -72.58% year-to-date.

According to 9 Wall Street analysts, the consensus rating for Aardvark Therapeutics, Inc. Common Stock stock is Buy, with an average 12-month price target of $22.75. In fiscal year 2025, Aardvark Therapeutics, Inc. Common Stock reported revenue of — and net income of -$57.6M. For detailed data — including Aardvark Therapeutics, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Aardvark Therapeutics, Inc. Common Stock (AARD) stock price is $3.59. The stock is traded on NASDAQ under the ticker symbol AARD. The 52-week range is $3.35 – $17.94.

AARD stock priceAARD quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice